PET measurement of hepatobiliary transport of Telmisartan in a therapeutic dose using [11C]Telmisartan in normal subjects as a determinant of nonlinear pharmacokinetics.

Trial Profile

PET measurement of hepatobiliary transport of Telmisartan in a therapeutic dose using [11C]Telmisartan in normal subjects as a determinant of nonlinear pharmacokinetics.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Aug 2016 Status changed from recruiting to completed.
    • 12 Apr 2012 Status changed from suspended to recruiting, according to the University Hospital Medical Information Network - Japan.
    • 12 Apr 2012 Planned End Date changed from 1 Mar 2011 to 1 Sep 2013, according to the University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top